<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04923503</url>
  </required_header>
  <id_info>
    <org_study_id>RMD</org_study_id>
    <nct_id>NCT04923503</nct_id>
  </id_info>
  <brief_title>Diurnal Ramadan Fasting on Appetite Hormone and Metabolic Profile Among Lean, Obesity, Diabetics</brief_title>
  <official_title>Department of Nutrition Science, Medical Faculty, Universitas Diponegoro, Semarang, Indonesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitas Diponegoro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitas Diponegoro</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetes Mellitus individuals are known to have dietary rules, namely regulating the amount,&#xD;
      type and time of eating. Ramadan fasting seems to be beneficial for people who want to reduce&#xD;
      their weight, but it is not easy for diabetic patients. Because of its distinctive features,&#xD;
      Ramadhan induces changes in eating habits, calorie consumption, sleeping patterns, and daily&#xD;
      physical activity, which may contribute to changes in hunger-satiety responses and glicemic&#xD;
      control. Examining changes in gut hormones during Ramadan fasting may reveal whether this&#xD;
      observance could change glucose metabolism in diabetics without triggering the undesirable&#xD;
      effect of gluconeogenesis. The proportions of fat, protein, and carbohydrate in meals vary&#xD;
      between outside and within Ramadan. Alterations in timing and composition meal during Ramadan&#xD;
      lead to reduced food intake may affect gut hormones and metabolic responses. The aim of this&#xD;
      study to determine whether the effect of Ramadan fasting differed in people with DM patients,&#xD;
      pre-DM and healthy individuals, with respect to gut hormones, body composition, metabolic&#xD;
      parameters, and glycemic control&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The experimental study was performed during and after Ramadan fasting in 2021 (April to May)&#xD;
      in Semarang, Indonesia. The present study was performed using the quasy-experimental method&#xD;
      by pre-post measurement of three experimental groups (diabetics, Obese and healthy subjects)&#xD;
      selected using the purposive sampling methods&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Actual">May 1, 2021</completion_date>
  <primary_completion_date type="Actual">April 12, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>three arm parallel group with 45 subjects:&#xD;
fasting in lean group&#xD;
fasting in obese group&#xD;
fasting in diabetics group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>subject with random allocation Investigator do not know the group the analysator do not know the group</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>change acylated ghrelin</measure>
    <time_frame>30 days</time_frame>
    <description>Change from Baseline acyl ghrelin at 30 days taken in the lab from venous blood specimen</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change PYY</measure>
    <time_frame>30 days</time_frame>
    <description>Change from Baseline PYY at 30 days taken in the lab from venous blood specimen</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change GLP-1</measure>
    <time_frame>30 days</time_frame>
    <description>Change from Baseline GLP-1 at 30 days taken in the lab from venous blood specimen</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change insulin</measure>
    <time_frame>30 days</time_frame>
    <description>Change from Baseline Insulin at 30 days taken in the lab from venous blood specimen</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change body weight</measure>
    <time_frame>30 days</time_frame>
    <description>Change from Baseline body weight at 30 days</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Fasting</condition>
  <condition>Gut Hormone</condition>
  <arm_group>
    <arm_group_label>lean ramadan fasting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>conduct ramadan fasting for 30 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>obese ramadan fasting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>conduct ramadan fasting for 30 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>diabetics ramadan fasting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>conduct ramadan fasting for 30 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>diurnal fasting</intervention_name>
    <description>subject conduct fasting in Ramadan for 30 days</description>
    <arm_group_label>diabetics ramadan fasting</arm_group_label>
    <arm_group_label>lean ramadan fasting</arm_group_label>
    <arm_group_label>obese ramadan fasting</arm_group_label>
    <other_name>ramadan fasting</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diabetics subjects: glucose fasting plasma &gt; 200 mg/dL, with aged 35-60 years and body&#xD;
             mass index above 25 kg/m;&#xD;
&#xD;
          -  Obese subjects: body mass index above 25 kg/m2 with aged 35-60 years and waist&#xD;
             circumference for men &gt;90 cm, for women &gt; 80 cm&#xD;
&#xD;
          -  Lean subjects: body mass index below 23.5 kg/m2 with aged 35-60 years and waist&#xD;
             circumference for men &lt;90 cm, for women &lt; 80 cm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  experienced weight loss more than 10% from the actual weight in the last three months&#xD;
&#xD;
          -  consumed medicine or supplement for weight loss diet, â€¢. had the history of evidence&#xD;
             of clinical depression, cognitive disorders, heart disease, cancer, liver or renal&#xD;
             disease, chronic pulmonary disease, uncontrolled hypertension, physical disability, or&#xD;
             other contraindications&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Etika R Noer</last_name>
    <role>Principal Investigator</role>
    <affiliation>Diponegoro University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Etika Ratna Noer</name>
      <address>
        <city>Semarang</city>
        <state>Central Java</state>
        <zip>50275</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 6, 2021</study_first_submitted>
  <study_first_submitted_qc>June 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2021</study_first_posted>
  <last_update_submitted>June 26, 2021</last_update_submitted>
  <last_update_submitted_qc>June 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitas Diponegoro</investigator_affiliation>
    <investigator_full_name>Etika Ratna Noer</investigator_full_name>
    <investigator_title>Department of Nutrition, Medical Faculty</investigator_title>
  </responsible_party>
  <keyword>gut hormones</keyword>
  <keyword>metabolic parameters</keyword>
  <keyword>obesity</keyword>
  <keyword>lean</keyword>
  <keyword>diabetics</keyword>
  <keyword>ramadan fasting</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>the result of this study is available to cite everyone</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>anytime</ipd_time_frame>
    <ipd_access_criteria>etikaratna@fk.undip.ac.id</ipd_access_criteria>
    <ipd_url>http://dept-gizi@fk.undip.ac.id</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

